Voyageur Pharmaceuticals Ltd Capital Reinvestment Ratio

Latest as of November 2023: 1.12x

Voyageur Pharmaceuticals Ltd capital reinvestment ratio. Voyageur Pharmaceuticals Ltd (VM) has a Capital Reinvestment Ratio of 1.12x as of November 2023, meaning it reinvests 1% of its operating cash flow (CA$29.56K) in capital expenditures (CA$33.21K). Check how aggressively does Voyageur Pharmaceuticals Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.12x

Capex / Operating Cash Flow

Operating Cash Flow

CA$29.56K

CAD

Capital Expenditures

CA$33.21K

CAD

Data as of

Nov 2023

Most recent filing

Voyageur Pharmaceuticals Ltd Capital Reinvestment Ratio by Year (None–None)

Voyageur Pharmaceuticals Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see VM cash flow conversion.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow